CVS
CVS CVS HEALTH Corp
-0.39 (-0.43%)91.33USD2.1M成交股數117B市值24.1本益比(近四季)0.3股價營收比+7.3%營收年增(近四季)2026-10-28下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 106B+7% | 100B+6% | 106B+11% | 103B+13% | 98.9B+12% | 94.6B+1% | 95.4B+6% | 91.2B+3% | 88.4B | 93.8B | 89.8B | 88.9B |
| 營業成本 | 58.9B | 55.4B | 59.1B | 57.0B | 54.0B | 51.1B | 52.9B | 50.0B | 48.1B | 57.4B | 54.7B | 53.5B |
| 毛利 | 47.2B+5% | 45.0B+3% | 46.6B+10% | 45.8B+11% | 44.9B+11% | 43.5B+20% | 42.5B+21% | 41.2B+17% | 40.4B | 36.4B | 35.1B | 35.4B |
| 毛利率 | 44.5% | 44.8% | 44.1% | 44.5% | 45.4% | 46.0% | 44.5% | 45.2% | 45.6% | 38.8% | 39.1% | 39.8% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業利益 | 4.7B+98% | 4.7B+39% | 2.1B+154% | −3.2B-205% | 2.4B+5% | 3.4B+0% | 832M-77% | 3.0B-6% | 2.3B | 3.4B | 3.7B | 3.2B |
| 營業利益率 | 4.4% | 4.7% | 2.0% | -3.1% | 2.4% | 3.6% | 0.9% | 3.3% | 2.6% | 3.6% | 4.1% | 3.6% |
| 稅後淨利 | 3.0B+192% | 2.9B+65% | 2.9B+3283% | −4.0B-325% | 1.0B-8% | 1.8B-13% | 87.0M-96% | 1.8B-7% | 1.1B | 2.0B | 2.3B | 1.9B |
| 淨利率 | 2.8% | 2.9% | 2.8% | -3.9% | 1.0% | 1.9% | 0.1% | 1.9% | 1.3% | 2.2% | 2.5% | 2.1% |
| 稀釋 EPS | 2.31+189% | 2.30+63% | 2.31+3200% | -3.13-322% | 0.80-9% | 1.41-11% | 0.07-96% | 1.41-5% | 0.88 | 1.59 | 1.75 | 1.48 |
| 稀釋股數 | 1.29B | 1.28B | 1.27B | 1.27B | 1.27B | 1.26B | 1.26B | 1.26B | 1.27B | 1.29B | 1.29B | 1.29B |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 11.3B | 9.5B | 8.5B | 9.1B | 11.8B | 10.1B | 6.9B | 12.5B | 9.8B | 8.2B | 13.0B | 13.8B |
| 應收帳款 | 40.3B | 41.0B | 39.8B | 43.9B | 40.7B | 39.6B | 36.2B | 32.4B | 32.2B | 35.2B | 32.9B | 29.5B |
| 存貨 | 17.6B | 17.8B | 19.2B | 19.0B | 17.4B | 17.4B | 17.6B | 16.1B | 16.3B | 18.0B | 18.0B | 17.3B |
| 總資產 | 254B | 253B | 254B | 255B | 258B | 256B | 252B | 252B | 250B | 250B | 251B | 250B |
| 有息負債 | 59.5B | 60.5B | 60.5B | 60.5B | 57.3B | 59.0B | 59.8B | 62.6B | 57.7B | 58.6B | 59.8B | 61.4B |
| 總負債 | 174B | 175B | 178B | 182B | 181B | 178B | 177B | 177B | 176B | 173B | 177B | 177B |
| 股東權益 | 79.7B | 77.5B | 75.2B | 72.9B | 77.4B | 76.9B | 74.9B | 74.9B | 74.0B | 76.5B | 74.3B | 72.7B |
| 負債比 | 68.5% | 69.3% | 70.3% | 71.4% | 70.0% | 69.8% | 70.2% | 70.3% | 70.3% | 69.3% | 70.4% | 70.8% |
| 淨現金(現金 − 有息負債) | −48.1B | −51.0B | −52.0B | −51.4B | −45.5B | −49.0B | −52.9B | −50.1B | −47.9B | −50.4B | −46.7B | −47.6B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 4.2B-7% | – | – | – | 4.6B | – | – | 4.9B | – | – | – |
| 資本支出 | – | 849M | – | – | – | 743M | – | – | 705M | – | – | – |
| 自由現金流 | – | 3.4B-11% | – | – | – | 3.8B | – | – | 4.2B | – | – | – |
| 折舊攤銷 | 1.1B | 1.1B | 1.1B | 1.1B | 1.2B | 1.2B | 1.2B | 1.2B | 1.1B | – | – | – |
| 買回庫藏股 | – | – | – | – | – | 0.00 | – | – | 3.0B | – | – | – |
| 現金股利 | – | 847M | – | – | – | 840M | – | – | 840M | – | – | – |
| 自由現金流率 | – | 3.4% | – | – | – | 4.0% | – | – | 4.7% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 473B
| Health Services | 190B | 40.2% | +9.7% |
|---|---|---|---|
| Health Care Benefits | 143B | 30.3% | +9.7% |
| Pharmacy And Consumer Health | 139B | 29.5% | +11.9% |
產品／服務2025 年度 · 265B
| 產品 | 250B | 94.3% | +7.9% |
|---|---|---|---|
| 服務 | 15.2B | 5.7% | -6.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 402B | +7.8% | 1.8B | 0.4% | 1.39 | 7.8B |
| FY2024 | 373B | +4.2% | 4.6B | 1.2% | 3.66 | 6.3B |
| FY2023 | 358B | +10.9% | 8.3B | 2.3% | 6.47 | 10.4B |
| FY2022 | 322B | +10.4% | 4.3B | 1.3% | 3.26 | 13.5B |
| FY2021 | 292B | +8.7% | 8.0B | 2.7% | 6.02 | 15.7B |
| FY2020 | 269B | +4.6% | 7.2B | 2.7% | 5.46 | 13.4B |
| FY2019 | 257B | +32.4% | 6.6B | 2.6% | 5.08 | 10.4B |
| FY2018 | 194B | – | −594M | -0.3% | -0.57 | 6.8B |